167 related articles for article (PubMed ID: 37324458)
1. Thymoquinone affects the gemcitabine sensitivity of pancreatic cancer by regulating collagen via hypoxia inducible factor-1α.
Zhao Z; Liu L; Chen H; Li S; Guo Y; Hou X; Yang J
Front Pharmacol; 2023; 14():1138265. PubMed ID: 37324458
[No Abstract] [Full Text] [Related]
2. Cancer-associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF-1α/miR-21 axis under hypoxic conditions in pancreatic cancer.
Deng K; Zou F; Xu J; Xu D; Luo Z
Mol Carcinog; 2024 Mar; 63(3):524-537. PubMed ID: 38197482
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factor-1α expression and gemcitabine chemotherapy for pancreatic cancer.
Kasuya K; Tsuchida A; Nagakawa Y; Suzuki M; Abe Y; Itoi T; Serizawa H; Nagao T; Shimazu M; Aoki T
Oncol Rep; 2011 Dec; 26(6):1399-406. PubMed ID: 21922147
[TBL] [Abstract][Full Text] [Related]
4. MGMT expression affects the gemcitabine resistance of pancreatic cancer cells.
Shi Y; Wang Y; Qian J; Yan X; Han Y; Yao N; Ma J
Life Sci; 2020 Oct; 259():118148. PubMed ID: 32721465
[TBL] [Abstract][Full Text] [Related]
5. Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling.
Wang B; Shen C; Li Y; Zhang T; Huang H; Ren J; Hu Z; Xu J; Xu B
Onco Targets Ther; 2019; 12():5751-5765. PubMed ID: 31410021
[No Abstract] [Full Text] [Related]
6. VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer
Kang G; Hu M; Ren H; Wang J; Cheng X; Li R; Yuan B; Balan Y; Bai Z; Huang H
Cancer Biol Med; 2021 Apr; 18(3):772-87. PubMed ID: 33830713
[TBL] [Abstract][Full Text] [Related]
7. Vav1-dependent Rac1 activation mediates hypoxia-induced gemcitabine resistance in pancreatic ductal adenocarcinoma cells through upregulation of HIF-1α expression.
Zhu C; Hu H; Ma Y; Xiong S; Zhu D
Cell Biol Int; 2023 Nov; 47(11):1835-1842. PubMed ID: 37545183
[TBL] [Abstract][Full Text] [Related]
8. Thymoquinone Selectively Kills Hypoxic Renal Cancer Cells by Suppressing HIF-1α-Mediated Glycolysis.
Lee YM; Kim GH; Park EJ; Oh TI; Lee S; Kan SY; Kang H; Kim BM; Kim JH; Lim JH
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30832444
[TBL] [Abstract][Full Text] [Related]
9. [Inhibitory effects of thymoquinone on human pancreatic carcinoma orthotopically implanted in nude mice].
Wang YM
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(44):3111-4. PubMed ID: 22340651
[TBL] [Abstract][Full Text] [Related]
10. Thymoquinone has a synergistic effect with PHD inhibitors to ameliorate ischemic brain damage in mice.
Amin N; Chen S; Ye S; Wu F; Hussien AB; Lou C; Hu Z; Wang Y; Wu J; Fang M
Phytomedicine; 2022 Sep; 104():154298. PubMed ID: 35797865
[TBL] [Abstract][Full Text] [Related]
11. SCF, regulated by HIF-1α, promotes pancreatic ductal adenocarcinoma cell progression.
Gao C; Li S; Zhao T; Chen J; Ren H; Zhang H; Wang X; Lang M; Liu J; Gao S; Zhao X; Sheng J; Yuan Z; Hao J
PLoS One; 2015; 10(3):e0121338. PubMed ID: 25799412
[TBL] [Abstract][Full Text] [Related]
12. IL-37/ STAT3/ HIF-1α negative feedback signaling drives gemcitabine resistance in pancreatic cancer.
Zhao T; Jin F; Xiao D; Wang H; Huang C; Wang X; Gao S; Liu J; Yang S; Hao J
Theranostics; 2020; 10(9):4088-4100. PubMed ID: 32226541
[TBL] [Abstract][Full Text] [Related]
13. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
[TBL] [Abstract][Full Text] [Related]
14. Curcumin inhibits pancreatic cancer cell proliferation by regulating Beclin1 expression and inhibiting the hypoxia-inducible factor-1α-mediated glycolytic pathway.
Guo W; Ding Y; Pu C; Wang Z; Deng W; Jin X
J Gastrointest Oncol; 2022 Dec; 13(6):3254-3262. PubMed ID: 36636058
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions.
Fan P; Zhang JJ; Wang B; Wu HQ; Zhou SX; Wang CY; Zhang JH; Tian Y; Wu HS
Pancreatology; 2012; 12(2):170-8. PubMed ID: 22487528
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of metformin enhancing the sensitivity of human pancreatic cancer cells to gem-citabine by regulating the PI3K/Akt/mTOR signaling pathway.
Zhou HY; Yao XM; Chen XD; Tang JM; Qiao ZG; Wu XY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10283-10289. PubMed ID: 31841183
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HIF-1α by PX-478 enhances the anti-tumor effect of gemcitabine by inducing immunogenic cell death in pancreatic ductal adenocarcinoma.
Zhao T; Ren H; Jia L; Chen J; Xin W; Yan F; Li J; Wang X; Gao S; Qian D; Huang C; Hao J
Oncotarget; 2015 Feb; 6(4):2250-62. PubMed ID: 25544770
[TBL] [Abstract][Full Text] [Related]
18. Effect of antisense hypoxia-inducible factor 1alpha on progression, metastasis, and chemosensitivity of pancreatic cancer.
Chang Q; Qin R; Huang T; Gao J; Feng Y
Pancreas; 2006 Apr; 32(3):297-305. PubMed ID: 16628086
[TBL] [Abstract][Full Text] [Related]
19. Depletion of pro-oncogenic RUNX2 enhances gemcitabine (GEM) sensitivity of p53-mutated pancreatic cancer Panc-1 cells through the induction of pro-apoptotic TAp63.
Ozaki T; Nakamura M; Ogata T; Sang M; Yoda H; Hiraoka K; Sang M; Shimozato O
Oncotarget; 2016 Nov; 7(44):71937-71950. PubMed ID: 27713122
[TBL] [Abstract][Full Text] [Related]
20. MiR-373-3p enhances the chemosensitivity of gemcitabine through cell cycle pathway by targeting CCND2 in pancreatic carcinoma cells.
Hu W; Liu Q; Pan J; Sui Z
Biomed Pharmacother; 2018 Sep; 105():887-898. PubMed ID: 30021382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
